EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access

Prognostic implications and predictive factors of subclinical leaflet thrombosis following valve-in-valve transcatheter aortic valve implantation

Takashi Nagasaka, Vivek Patel, Kazuki Suruga, Yuchao Guo, Ofir Koren, Alon Shechter, Michelle Friedman, Dhairya Patel, Tarun Chakravarty, Wen Cheng, Aakriti Gupta, Hideki Ishii und 3 weitere

EuroIntervention · 2025

DOI: 10.4244/eij-d-24-00711 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift EuroIntervention, 2025. Verfasst von Takashi Nagasaka und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cedars-Sinai Medical Center, Smidt Heart Institute, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Aortic Valve, Aortic Valve Stenosis, Heart Valve Prosthesis, Thrombosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Subclinical leaflet thrombosis, as indicated by hypoattenuated leaflet thickening (HALT) on computed tomography (CT) imaging, remains a major concern owing to its potential impact on valve function and patient outcomes. AIMS: We aimed to evaluate the association between HALT and clinical outcomes in patients undergoing valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) with balloon-expandable valves and to identify predictors of leaflet thrombosis. METHODS: Consecutive patients who underwent ViV TAVI with balloon-expandable valves at the Cedars-Sinai Medical Center were retrospectively analysed. We analysed both pre- and postprocedural CT scans to identify predictors of HALT at 1 month after ViV TAVI and the association of HALT with clinical outcomes. The primary outcome was a composite of all-cause mortality, hospitalisation for heart failure (HF), or stroke at 3 years. RESULTS: Among the 117 patients analysed, HALT was detected in 37 (31.6%). In the multivariable analysis, anticoagulation therapy (odds ratio [OR] 0.28, 95% confidence interval [CI]: 0.08-0.92; p=0.037) and greater transcatheter heart valve (THV) expansion at the minimum area level (OR 0.95, 95% CI: 0.91-0.99; p=0.026) were significant predictors of reduced HALT following ViV TAVI. While there was no significant difference in all-cause mortality between patients with and without HALT (OR 1.13, 95% CI: 0.42-3.02; p=0.8), those with HALT had a significantly higher incidence of the composite primary outcome (OR 2.31, 95% CI: 1.04-5.15; p=0.04). CONCLUSIONS: HALT was frequently observed in patients who underwent ViV TAVI. Additionally, the presence of HALT correlated with a higher incidence of composite outcomes, including all-cause mortality, hospitalisation for HF, and stroke. Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic VaLVe Dysfunction and Its TrEatment with Anticoagulation (RESOLVE; ClinicalTrials.gov: NCT02318342).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic ValveAortic Valve StenosisHeart Valve ProsthesisThrombosisTranscatheter Aortic Valve ReplacementAgedAged, 80 and overFemaleHumansMaleAnticoagulantsPrognosisRetrospective StudiesRisk FactorsTomography, X-Ray ComputedTreatment OutcomeProspective Studies

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Cedars-Sinai Medical Center, Smidt Heart Institute, Los Angeles, CA, USA.
  • Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Gunma, Japan.
  • Department of Cardiology of The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, and State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China, and Cardiovascular K…
  • Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
  • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Zitieren

APA

Nagasaka, T., Patel, V., Suruga, K., Guo, Y., Koren, O., Shechter, A., Friedman, M., Patel, D., Chakravarty, T., Cheng, W., Gupta, A., Ishii, H., Jilaihawi, H., Nakamura, M., & Makkar, R. R. (2025). Prognostic implications and predictive factors of subclinical leaflet thrombosis following valve-in-valve transcatheter aortic valve implantation. EuroIntervention. https://doi.org/10.4244/eij-d-24-00711

Vancouver

Nagasaka T, Patel V, Suruga K, Guo Y, Koren O, Shechter A, et al. Prognostic implications and predictive factors of subclinical leaflet thrombosis following valve-in-valve transcatheter aortic valve implantation. EuroIntervention. 2025. doi:10.4244/eij-d-24-00711

BibTeX
@article{Nagasaka2025,
  author = {Nagasaka, Takashi and Patel, Vivek and Suruga, Kazuki and Guo, Yuchao and Koren, Ofir and Shechter, Alon and Friedman, Michelle and Patel, Dhairya and Chakravarty, Tarun and Cheng, Wen and Gupta, Aakriti and Ishii, Hideki and Jilaihawi, Hasan and Nakamura, Mamoo and Makkar, Raj R},
  title = {Prognostic implications and predictive factors of subclinical leaflet thrombosis following valve-in-valve transcatheter aortic valve implantation},
  journal = {EuroIntervention},
  year = {2025},
  doi = {10.4244/eij-d-24-00711}
}
Kostenlos starten →